Compare BWEN & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BWEN | ATRA |
|---|---|---|
| Founded | N/A | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.5M | 94.2M |
| IPO Year | 2009 | 2014 |
| Metric | BWEN | ATRA |
|---|---|---|
| Price | $2.93 | $9.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $6.83 | ★ $13.67 |
| AVG Volume (30 Days) | ★ 177.8K | 27.8K |
| Earning Date | 11-12-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 360.00 | 122.52 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $146,785,000.00 | $120,772,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.73 | $1,334.59 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.92 | $3.92 |
| 52 Week High | $5.70 | $19.15 |
| Indicator | BWEN | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 24.27 | 50.08 |
| Support Level | $1.98 | $8.94 |
| Resistance Level | $3.35 | $9.93 |
| Average True Range (ATR) | 0.19 | 0.56 |
| MACD | -0.09 | -0.00 |
| Stochastic Oscillator | 0.00 | 36.14 |
Broadwind Inc is a precision manufacturer of structures, equipment, and components for clean technology and other specialized applications. The company provides technologically high-value products to customers with complex systems and stringent quality standards that operate in the energy, mining, and infrastructure sectors in the United States of America. Its capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treatment, CNG decompression, precision machining, assembly, engineering, and packaging solutions, among others. The company operates in four reportable segments: Heavy Fabrications, which generates the maximum revenue, Gearing, Industrial Solutions, and Corporate.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.